Takeda, the manufacturer of Actos, has agreed to pay $nearly $2.4 billion to settle bladder cancer claims brought by users: 

1. who  took Actos at some time prior to December 1, 2011,
2. who were diagnosed with bladder cancer on or before April 28, 2015, and
3. who retained counsel before May 1, 2015. Under the terms of

…